midazolam has been researched along with raltegravir potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeNoia, EP; Ghosh, K; Gottesdiener, KM; Hanley, WD; Iwamoto, M; Kassahun, K; Lu, P; Mangin, E; Petry, AS; Rhoton, A; Stone, JA; Troyer, MD; Wagner, JA; Wenning, LA | 1 |
| Hee, KH; Lee, LS; Yao, Z | 1 |
2 trial(s) available for midazolam and raltegravir potassium
| Article | Year |
|---|---|
Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation.
Topics: Area Under Curve; Cells, Cultured; Chromatography, Liquid; Cross-Over Studies; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; Hepatocytes; HIV Integrase Inhibitors; Humans; Male; Mass Spectrometry; Metabolic Clearance Rate; Microsomes, Liver; Midazolam; Organic Chemicals; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Simultaneous determination of probe drugs, metabolites, inhibitors and inducer in human plasma by liquid chromatography/tandem mass spectrometry and its application to pharmacokinetic study.
Topics: Calibration; Chromatography, Liquid; Cross-Over Studies; Cytochrome P-450 CYP3A; Freezing; Glucuronosyltransferase; Healthy Volunteers; Humans; Ketoconazole; Midazolam; Particle Size; Pyrrolidinones; Quality Control; Raltegravir Potassium; Reproducibility of Results; Rifampin; Ritonavir; Solid Phase Extraction; Tandem Mass Spectrometry; Xenobiotics | 2014 |